相关实验视频

Updated: May 24, 2025

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

在无形性贫血中对免疫抑制疗法的反应的预测标记

Maya Gupta¹, Manisha Madkaikar¹

¹Paediatric Immunology and Leucocytes Biology Department, ICMR-National Institute of Immunohematology, Mumbai, India.

Scandinavian journal of immunology

|March 4, 2025

概括

对无形性贫血 (AA) 治疗反应的预测标志物至关重要. 本综述探讨了临床,免疫和遗传标记,以个性化免疫抑制疗法 (IST) 并改善患者的治疗结果.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
遗传学遗传学是一个

背景情况:

无形性贫血 (AA) 是一种罕见的,危及生命的骨髓衰竭疾病.
目前的治疗方法包括造血干细胞移植 (HSCT) 和免疫抑制疗法 (IST),每一种都有局限性.
需要个性化治疗策略,因为IST的疗效和复发或转变的风险各不相同.

研究的目的:

审查临床,免疫和遗传标记,预测AA患者对IST的反应.
突出需要验证的预测标记,以实现个性化治疗和改善结果.

主要方法:

在AA中识别IST反应的潜在预测标记的研究文献综述.
专注于临床,免疫学 (例如,细胞因子水平) 和遗传标记 (例如,端粒长度,PNH克隆大小).

主要成果:

一些标记物,包括细胞因子水平,端粒长度和PNH克隆大小,显示出预测IST反应的潜力.
目前的证据很大程度上来自于有方法不一致的追溯研究.
有限的可复制性阻碍了这些标记物的临床实施.

结论:

验证的预测标记是个性化IST在AA的必要条件.
需要进行标准化,大规模的前性研究来确认标记物的有用性.
开发一个综合临床和分子数据的评分系统可以提高AA管理和患者的结果.

关键词:

无塑性贫血是什么意思血液计数血液计数血液计数免疫细胞免疫细胞免疫抑制疗法是一种免疫抑制疗法.预测者预测者预测者

更多相关视频

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry

Published on: April 19, 2017

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...